Louise E. Glover0000-0001-9056-1810
Louise E. Glover received her Ph.D. degree at University College Dublin in Dublin, Ireland, in 2003. Then, she moved to Massachusetts General Hospital (Boston, Mass, USA) and Harvard Medical School (Boston, Mass, USA), where she completed a Postdoctoral Fellowship in the Cecil B. Day laboratory for Neuromuscular Research. Glover was recruited to the Mucosal Inflammation Program at the University of Colorado Denver (Denver, Colo, USA) in 2007, and one year later she joined the faculty in the Division of Gastroenterology and Hepatology. Dr. Glover was promoted to the rank of Assistant Professor at University Colorado Denver in 2011. Her major research interests include metabolic signaling in mucosal inflammatory loci, particularly in the context of inflammation-associated hypoxia and transcriptional regulation by the hypoxia-inducible factors (HIFs). Her work is aimed at identification of novel pathways orchestrated by HIF in intestinal epithelial cells and understanding how these pathways fundamentally contribute to epithelial homeostasis and barrier function in inflammatory bowel disease (IBD).
Biography Updated on 7 February 2013